1.
PET Clin
; 19(2): 281-290, 2024 Apr.
Article
in English
| MEDLINE
| ID: mdl-38403384
ABSTRACT
The clinical landscape of lymphomas has changed dramatically over the last 2 decades, including significant progress made in the understanding and utilization of imaging modalities and the available treatment options for both indolent and aggressive lymphomas. Since the introduction of hybrid PET/CT scanners in 2001, the indications of 18F-fluorodeoxyglucose (FDG) PET/CT in the management of lymphomas have grown rapidly. In today's clinical practice, FDG PET/CT is used in successful management of the vast majority patients with lymphomas.
Subject(s)
Lymphoma , Positron Emission Tomography Computed Tomography , Humans , Fluorodeoxyglucose F18 , Lymphoma/diagnostic imaging , Lymphoma/therapy , Positron-Emission Tomography/methods
2.